Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medical economics"
DOI: 10.1080/13696998.2023.2187604
Abstract: BACKGROUND Cholangiocarcinoma (CCA) is associated with poor prognosis. Healthcare-related management likely presents a substantial economic burden associated with time away from work in patients with CCA. OBJECTIVES To assess productivity loss, associated indirect costs, and… read more here.
Keywords: disability; productivity; term disability; patients cca ... See more keywords
Second primary malignancy in patients with cholangiocarcinoma: a population-based study
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Management and Research"
DOI: 10.2147/cmar.s187614
Abstract: Background A population-based estimate of risk of second primary malignancy (SPM) in patients with cholangiocarcinoma (CCA) is still lacking. Objectives To investigate the overall and site-specific risk of SPM in patients with CCA. To identify… read more here.
Keywords: primary malignancy; patients cca; spm patients; risk ... See more keywords
Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.989080
Abstract: Background Cholangiocarcinoma (CCA) is a malignant tumor originating from bile duct epithelial cells that no obvious clinical symptoms and specific clinical manifestations are shown in the early stage of CCA. Methods Propensity score matching (PSM)… read more here.
Keywords: propensity score; patients cca; losartan group; patients losartan ... See more keywords
Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Public Health"
DOI: 10.3389/fpubh.2022.766023
Abstract: Gemcitabine and cisplatin serve as appropriate treatments for patients with cholangiocarcinoma (CCA). Our previous study using histoculture drug response assay (HDRA), demonstrated individual response patterns to gemcitabine and cisplatin. The current study aimed to identify… read more here.
Keywords: patients cholangiocarcinoma; patients cca; metabolic phenotyping; gemcitabine cisplatin ... See more keywords
Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma
Sign Up to like & getrecommendations! Published in 2020 at "Oncology Letters"
DOI: 10.3892/ol.2019.11162
Abstract: Coiled-coil domain containing 25 (CCDC25) was previously reported to be upregulated in cholangiocarcinoma (CCA) tissues compared with adjacent normal tissues. The present study investigated whether serum CCDC25 level may be used as a potential marker… read more here.
Keywords: patients cca; serum ccdc25; ccdc25 level;